Lymphoma Research Foundation

That’s a wrap on the #TCellWorkshop2025! Thank you to all the speakers, researchers, and attendees advancing the future of T-cell lymphoma science. Together, we move closer to cures. To learn more about the Foundation's scientific programs and initiatives, visit https://lnkd.in/eB-A5FU9 #PTCL #CTCL #LymphomaScience

Our final session of the #TCellWorkshop2025 features a conversation between session chairs Francine Foss, MD, FAAD (Yale School of Medicine), Youn Kim, MD (Stanford University School of Medicine), and Steven Horwitz, MD (Memorial Sloan Kettering Cancer Center) setting out a research roadmap for #PTCL and #CTCL. Conversations like these provide opportunities for collaboration that can lead to major breakthroughs and major impacts.

Special #CTCL Session has begun at the #TCellWorkshop2025, planned in partnership with our incredible colleagues at the Cutaneous Lymphoma Foundation.

For those diagnosed with cutaneous lymphomas, the first signs often appear on the skin. Cutaneous lymphomas are rare and often misunderstood. At the #TCellWorkshop2025, Drs. Pierluigi Porcu (Jefferson Health), Youn Kim (Stanford University School of Medicine), Maarten Vermeer (Leiden University Medical Center), and Jaehyuk Choi (UT Southwestern Medical Center) discuss CTCL pathology, immunotherapy, and precision medicine. We’re working on a better roadmap for patients with rare subtypes of T-cell lymphoma. #CTCL #LymphomaResearch 

We are excited to be partnering with the Cutaneous Lymphoma Foundation for our #TCellWorkshop2025. Scientific meetings like these offer crucial opportunities for collaboration and conversation and can lead to new innovations and breakthroughs that make a tangible impact for patients.

Clinical trials play a crucial role in advancing research and providing access to cutting-edge treatments. How do we design better trials for rare and heterogeneous diseases? Foundation Scientific Advisory Board member Kerry Savage, MD (BC Cancer) along with Foundation grantees Neha Mehta-Shah, MD, MSCI (Washington University School of Medicine in St. Louis) and Matthew Maurer, MD, DMSc (Mayo Clinic) share innovative approaches shaping the next era of lymphoma clinical trials. #ClinicalTrials #RareCancers 

We're starting the last day of the #TCellWorkshop2025 with cutting-edge insights on epigenetic therapy, CAR T-cell therapy, and therapeutic targeting in #TCellLymphomas. Speaker highlights include Enrica Marchi, MD, PhD, (University of Virginia School of Medicine), Swaminathan P iyer, MD (MD Anderson Cancer Center), Alison Moskowitz, MD (Memorial Sloan Kettering Cancer Center), Jasmine Zain, MD (Memorial Sloan Kettering Cancer Center), and Maksim Mamonkin, MD (Baylor College of Medicine).

Honored to participate in this important meeting focused exclusively on T-cell Lymphomas. Excited to see the synergism and advances this meeting will bring and thankful for the extraordinary support the LRF towards improving our understanding of these diseases. 

Raise your hand AND your paddle if you support life-saving and groundbreaking cancer research! I can't wait to join Matthew Wolniewicz, AIFA, next week for the Lymphoma Research Foundation's Partners in Purpose Event, where we will MC the "paddle raise" with a mission of raising $150,000 throughout the evening. If you can't join us at the historic Casino Club, you can still make an impact: 👉 Donate here: https://lnkd.in/gztezsp8 #relentless

Wrapping up Day 2 of #TCellWorkshop2025 with Session III, exploring therapeutic targets and #PTCL with Scientific Advisory Board members Kojo Elenitoba-Johnson, MD (Memorial Sloan Kettering Cancer Center) and Markus Müschen, MD, PhD (Yale School of Medicine), and Drs. Jürgen Ruland (Technical University of Munich) and Michael Khodadoust (Stanford University School of Medicine). #CancerInnovation #TCellTherapies